Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Aevi Genomic Medicine (GNMX)

1.415 +0.135 (+10.547%)

6/26/2017  12:59pm

Open:

1.330

Pre. Close:

1.280

High:

1.430

Low:

1.300

Volume:

420,714

Market Cap:

52.51M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.49 - 1.54

1.54 - 1.59

Low:

1.21 - 1.23

1.23 - 1.25

Close:

1.24 - 1.3

1.3 - 1.36

Technical analysis  (as of: 2017-06-26 12:54:00 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.75     One year: 2.05

Support:

Support1: 1.18    Support2: 0.98

Resistance:

Resistance1: 1.50    Resistance2: 1.75

Pivot:

1.28

Moving Averages:

MA(5): 1.37     MA(20): 1.25

MA(100): 2.68     MA(250): 4.33

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 61.00     %D(3): 69.20

RSI:

RSI(14): 52.94

52-Week:

High: 6.890  Low: 0.980  Change(%): -74.3

Average Vol(K):

3-Month: 500  10-Days 632

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GNMX has closed below upper band by 15.7%. Bollinger Bands are 74.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNMX's normal range. The bands have been in this narrow range for 52 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 15 Dec 2016 13:11:04 GMT
Medgenics, Inc. Announces Name Change to Aevi Genomic Medicine, Inc.

Wed, 09 Sep 2015 12:31:07 GMT
Medgenics Acquires Phase 2-Ready CNS Program: NFC-1

Tue, 21 Jun 2016 16:59:58 GMT
Why Medgenics Inc.'s Shares Are Down Big Today

Mon, 10 Oct 2016 20:26:15 GMT
Medgenics, Inc. to Begin Trading on NASDAQ Global Market

Tue, 13 Oct 2015 12:06:00 GMT
Medgenics Announces Key Appointments

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA

Industry:  NA

Shares Out. (M)

37.11

Shares Float (M)

25.22

% Held by Insiders

% Held by Institutions

Shares Short (K)

2090

Shares Short Prior Month (K)

1810

Stock Financials

EPS

-1.150

EPS Est. Current Year

-1.080

EPS Est. Next Year

-1.430

EPS Est. Next Quarter

-0.250

Forward EPS

-1.425

Book Value (p.s.)

0.680

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-68.8

Return on Equity (ttm)

-125.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.116

Qtrly Earnings Growth

Operating Cash Flow (M)

-34.30

Levered Free Cash Flow (M)

-18.87

FoxReading.com

Valuation

P/E

-1.22

P/E Growth Ratio

0.09

P/BV

2.06

P/S

P/CF

-1.51

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-01-05

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.